HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David E Briles Selected Research

pneumococcal surface protein A

10/2015Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
9/2014Preparation and testing of a Vi conjugate vaccine using pneumococcal surface protein A (PspA) from Streptococcus pneumoniae as the carrier protein.
7/2014Mapping of epitopes recognized by antibodies induced by immunization of mice with PspA and PspC.
12/2013A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA).
10/2012The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci in vitro.
2/2011A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice.
1/2011Maternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspring.
1/2011Protection of pneumococcal infection by maternal intranasal immunization with pneumococcal surface protein A.
7/2009Virulence of pneumococcal proteins on the inner ear.
10/2008Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David E Briles Research Topics

Disease

38Pneumococcal Infections
01/2021 - 04/2002
33Infections
01/2022 - 01/2003
13Pneumonia (Pneumonitis)
01/2021 - 05/2002
11Otitis Media
10/2017 - 02/2004
9Sepsis (Septicemia)
01/2020 - 08/2003
6Pneumococcal Pneumonia
01/2022 - 08/2003
4Bacterial Infections (Bacterial Infection)
10/2017 - 09/2007
4Inflammation (Inflammations)
09/2016 - 01/2008
3Bacteremia
01/2020 - 01/2003
3Respiratory Tract Infections (Respiratory Tract Infection)
05/2013 - 04/2003
2Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis)
01/2020 - 01/2016
2Meningitis
12/2015 - 10/2015
2Otitis Media with Effusion
09/2013 - 11/2010
1Coinfection
01/2021
1Lung Diseases (Lung Disease)
10/2018
1Autolysis
12/2017
1Atherosclerosis
06/2017
1Cardiovascular Diseases (Cardiovascular Disease)
06/2017
1Typhoid Fever (Typhoid)
09/2014
1Communicable Diseases (Infectious Diseases)
01/2013
1Fibrosis (Cirrhosis)
09/2012
1Non-alcoholic Fatty Liver Disease
09/2012
1Disease Progression
06/2012
1Necrosis
06/2012
1Sensorineural Hearing Loss
12/2008
1Hearing Loss (Hearing Impairment)
12/2008

Drug/Important Bio-Agent (IBA)

20VaccinesIBA
01/2021 - 04/2003
16pneumococcal surface protein AIBA
10/2015 - 03/2003
13Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2003
9Polysaccharides (Glycans)IBA
01/2022 - 02/2004
9Conjugate VaccinesIBA
01/2020 - 08/2003
8AntibodiesIBA
06/2017 - 08/2003
7AntigensIBA
06/2017 - 04/2003
6Membrane Proteins (Integral Membrane Proteins)IBA
07/2014 - 05/2002
5Streptococcus pneumoniae plY proteinIBA
01/2021 - 08/2003
4CytokinesIBA
12/2015 - 09/2007
3flt3 ligand protein (flt3 ligand)IBA
06/2017 - 09/2007
3Carrier Proteins (Binding Protein)IBA
10/2015 - 04/2009
2Combined VaccinesIBA
01/2022 - 09/2014
24-nitrophenethyl bromide (NPB)IBA
01/2021 - 05/2010
2Capsules (Microcapsules)IBA
10/2018 - 02/2010
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2017 - 09/2007
2Virulence Factors (Pathogenicity Factors)IBA
09/2016 - 07/2009
2Attenuated VaccinesIBA
01/2013 - 03/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2012 - 09/2007
2LactoferrinIBA
02/2010 - 01/2003
2CC ChemokinesIBA
04/2009 - 05/2007
2LigandsIBA
04/2009 - 05/2007
2EnzymesIBA
10/2008 - 11/2007
2ZincIBA
01/2008 - 04/2003
2Complement System Proteins (Complement)IBA
12/2007 - 01/2003
2Immunoglobulin G (IgG)IBA
11/2007 - 12/2002
2Complement Receptors (Complement Receptor)IBA
12/2004 - 12/2002
1Lactate Dehydrogenase 5IBA
01/2021
1Amino AcidsFDA Link
01/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2021
1Lactic Acid (Lactate)FDA LinkGeneric
01/2021
1SmokeIBA
11/2018
1Immune Sera (Antisera)IBA
01/2018
1small cardioactive peptide BIBA
01/2018
1Lipase (Acid Lipase)FDA Link
12/2017
1FibrinIBA
10/2017
1Complementary DNA (cDNA)IBA
06/2017
1OligodeoxyribonucleotidesIBA
06/2017
1N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2016
1aluminum sulfate (alum)IBA
10/2015
1Choline (Choline Chloride)IBA
10/2015
1Ethanol (Ethyl Alcohol)IBA
01/2015
1Peroxidase (Myeloperoxidase)IBA
01/2015
1polyethylene glycol polyethyleneimine nanogelIBA
05/2013
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2012
1Scavenger Receptors (Scavenger Receptor)IBA
09/2012
1oxidized low density lipoproteinIBA
09/2012
1Interleukin-6 (Interleukin 6)IBA
09/2012
1Immunoglobulin M (IgM)IBA
09/2012
1LipidsIBA
09/2012
1CholesterolIBA
06/2012
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
03/2012
1Neuraminidase (Sialidase)IBA
06/2011
1Penicillins (Penicillin)FDA Link
06/2011
1Tumor Viral Antigens (Large T Antigen)IBA
06/2011
1Thomsen-Friedenreich antigenIBA
06/2011
1CPG-oligonucleotideIBA
02/2011
1Secretory Immunoglobulin A (SIgA)IBA
02/2011
1apolactoferrinIBA
11/2010
1SB 225002IBA
06/2010
1Interleukin-8B ReceptorsIBA
06/2010
1Monoclonal AntibodiesIBA
05/2010
1Proline (L-Proline)FDA Link
05/2010
1EpitopesIBA
05/2010
1Anti-Bacterial Agents (Antibiotics)IBA
02/2010
1DaptomycinFDA Link
02/2010
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
02/2010
1LipopeptidesIBA
02/2010
1Surface Antigens (Surface Antigen)IBA
07/2009
1Chemotactic FactorsIBA
04/2009
1PolyaminesIBA
04/2009
1Immunoglobulin A (IgA)IBA
11/2007
1NF-kappa B (NF-kB)IBA
08/2007

Therapy/Procedure

1Ambulatory Care (Outpatient Care)
09/2014